← FDA Drug Approvals (Drugs@FDA)
BRYHALI
NDA · New Drug Application · Sponsor: BAUSCH · Approved 2018-11-06
Drug application
- FDA Application #
NDA209355- Application type
- New Drug Application
- Brand name
- BRYHALI
- Generic name
- HALOBETASOL PROPIONATE
- Active ingredients
- HALOBETASOL PROPIONATE
- Dosage form
- LOTION
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- BAUSCH
- Manufacturer
- Bausch Health US, LLC
- First approval
- 2018-11-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown